Up a level |
Plumpton, Catrin O, Alfirevic, Ana ORCID: 0000-0002-2801-9817, Pirmohamed, Munir ORCID: 0000-0002-7534-7266 and Hughes, Dyfrig A ORCID: 0000-0001-8247-7459
(2017)
Cost effectiveness analysis of HLA-B*58:01 genotyping prior to initiation of allopurinol for gout.
Rheumatology (Oxford, England), 56 (10).
pp. 1729-1739.
Hughes, Dyfrig A ORCID: 0000-0001-8247-7459, Culeddu, Giovanna, Plumpton, Catrin O, Wood, Eifiona, Dick, Andrew D, Jones, Ashley P, McKay, Andrew ORCID: 0000-0003-1312-8911, Williamson, Paula R ORCID: 0000-0001-9802-6636, Lacassagne, Sandrine Compeyrot, Hardwick, Ben et al (show 4 more authors)
(2019)
Cost-Effectiveness Analysis of Adalimumab for the Treatment of Uveitis Associated with Juvenile Idiopathic Arthritis.
Ophthalmology, 126 (3).
pp. 415-424.
Ridyard, Colin H, Plumpton, Catrin O, Gilbert, Ruth E and Hughes, Dyfrig A ORCID: 0000-0001-8247-7459
(2017)
Cost-Effectiveness of Pediatric Central Venous Catheters in the UK: A Secondary Publication from the CATCH Clinical Trial.
FRONTIERS IN PHARMACOLOGY, 8 (SEP).
644-.
Plumpton, Catrin O, Pirmohamed, Munir ORCID: 0000-0002-7534-7266 and Hughes, Dyfrig A ORCID: 0000-0001-8247-7459
(2019)
Cost‐Effectiveness of Panel Tests for Multiple Pharmacogenes Associated With Adverse Drug Reactions: An Evaluation Framework.
Clinical pharmacology and therapeutics, 105 (6).
pp. 1429-1438.
Marson, Anthony G ORCID: 0000-0002-6861-8806, Burnside, Girvan ORCID: 0000-0001-7398-1346, Appleton, Richard, Smith, Dave, Leach, John Paul, Sills, Graeme, Tudur-Smith, Catrin ORCID: 0000-0003-3051-1445, Plumpton, Catrin O, Hughes, Dyfrig A ORCID: 0000-0001-8247-7459, Williamson, Paula R ORCID: 0000-0001-9802-6636 et al (show 9 more authors)
(2021)
Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs Introduction.
HEALTH TECHNOLOGY ASSESSMENT, 25 (75).
1-+.